Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Oettle et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d70f295413bc3de5ab3523 — DOI: https://doi.org/10.1001/jama.2013.279201

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection· 2010 · 1,387 citations
2. Adjuvant Treatment for Resectable Pancreatic Cancer· 2005 · 72 citations
3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.· 1997 · 5,873 citations
4. Randomized multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and a prospective evaluation of the of the association between tumor hENT1 expression and clinical outcome with gemcitabine treatment.· 2013 · 12 citations
5. Asymptotically Efficient Rank Invariant Test Procedures· 1972 · 3,400 citations